Jilin Aodong Pharmaceutical Group Co., Ltd. Operating Cash Flow for the year ending December 31, 2024: USD 8.15 M

Jilin Aodong Pharmaceutical Group Co., Ltd. Operating Cash Flow is USD 8.15 M for the year ending December 31, 2024, a -15.02% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
  • Jilin Aodong Pharmaceutical Group Co., Ltd. Operating Cash Flow for the year ending December 31, 2023 was USD 9.59 M, a -84.39% change year over year.
  • Jilin Aodong Pharmaceutical Group Co., Ltd. Operating Cash Flow for the year ending December 31, 2022 was USD 61.42 M, a 20.14% change year over year.
  • Jilin Aodong Pharmaceutical Group Co., Ltd. Operating Cash Flow for the year ending December 31, 2021 was USD 51.12 M, a -14.52% change year over year.
  • Jilin Aodong Pharmaceutical Group Co., Ltd. Operating Cash Flow for the year ending December 31, 2020 was USD 59.81 M, a 9.76% change year over year.
Key Data
Date Operating Cash Flow Capital Expenditure Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities